Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Drug prices prescription drugs

Report to the president prescription drug coverage, spending, utilization, and prices. Dept, of Health and Human Services, 2000, pp. 123-124. [Pg.806]

However, the situation most commonly recognized is that competition in the market of patented prescription drugs is insufficient to produce an optimum level of information or an optimum level of welfare, which makes it necessary to establish some form of regulation. However, price regulation in the markets of non-prescription drugs and drugs whose patent has expired lacks theoretical justification. [Pg.38]

Kolassa, E.M. (1995), Physicians perceptions of prescription drug prices their accuracy and effect on the prescribing decision , Journal of Research and Pharmaceutical Economics, 6 (1), 23-37. [Pg.123]

Stuart, B. et al. (2000), Issues in prescription drug coverage, pricing, utilization and spending what we know and need to know , report prepared for US Department of Health and Human Services, Office of the Assistant Secretary for Policy and Evaluation, Office of Health Policy, Washington, DC, February, accessed at http //www.aspe.hhs.gov/health/reports/drugstudy/appa.htm. [Pg.144]

Doonan, M., "The Economics of Prescription Drug Pricing," Schneider Institute for Health Policy, Heller School for Social Policy and Management, Brandeis University, Waltham, MA, pp. 5-6 (2001). [Pg.285]

The vast bulk of prescription drugs on the market today are subject to the requirement for some form of an approved NDA. Following enactment of the Drug Price Competition and Patent Term Restoration Act of 1984, there are now three clearly established types of NDA a full NDA, a paper NDA [now called a Section 505(b)(2) NDA, after the provision in the FD C Act that created it], and an abbreviated NDA. Each of these is discussed in the sections that follow. [Pg.582]

For purposes of enforcing the law, FDA inspectors may at any time inspect any non-prescription or prescription drug. For both, FDA inspectors may see all records and documents except those that relate to financial data, sales data other than shipment data, pricing data, personnel data and research data. An FDA inspector may spend whatever amoimt of time is necessary to complete such an inspection - even weeks or months. Where significant enforcement issues have been found, FDA inspectors have been known to spend more than a year at a single establishment. [Pg.596]

High prices for prescription drugs. Americans are now convinced that they are pa)dng more for drugs than residents in Canada and elsewhere. Moreover, those not covered by health insurance purportedly have to choose between food and their medicines. [Pg.628]

Prescription drugs have many complex characteristics, which, when taken together, have led to major controversies in public policy arenas, including pricing, patents, and incentives for research and development, as well as excess industry profits. Each characteristic is not unique to pharmaceuticals, but rather it is the characteristics, taken in combination, that make the industry unique. [Pg.1]

This will involve two facets. First, where patients now enjoy full or nearly full insurance coverage for prescription drugs, they are likely to be asked to assume a larger share of the cost of drug therapy, if only to focus their minds on the relative cost effectiveness of rival products. Second, however, to allow both patients and their physicians to act as more cost-conscious purchasers of prescription drugs, an information infrastructure will emerge, or should emerge, that can provide potential users of pharmaceutical products with objective, science-based information on the prices and relative... [Pg.47]

A more in-depth discussion of reference pricing lies beyond the compass of this essay (in this regard, see Kanavos and Reinhardt 2003). Suffice it to say, it is a powerful method of introducing market power on the demand side of prescription drugs covered by health insurance, and one likely to be embraced, sooner or later, by private health insurers, as they seek to cope with the ever-rising cost of health care. [Pg.50]


See other pages where Drug prices prescription drugs is mentioned: [Pg.746]    [Pg.4]    [Pg.18]    [Pg.775]    [Pg.799]    [Pg.805]    [Pg.815]    [Pg.816]    [Pg.14]    [Pg.35]    [Pg.79]    [Pg.79]    [Pg.92]    [Pg.171]    [Pg.197]    [Pg.236]    [Pg.10]    [Pg.11]    [Pg.422]    [Pg.558]    [Pg.25]    [Pg.25]    [Pg.576]    [Pg.590]    [Pg.592]    [Pg.593]    [Pg.623]    [Pg.6]    [Pg.11]    [Pg.14]    [Pg.16]    [Pg.37]    [Pg.44]    [Pg.46]    [Pg.47]    [Pg.48]    [Pg.49]    [Pg.50]   


SEARCH



Drug prices

Prescription drugs prices

Prescription drugs prices

Pricing policy prescription drugs

© 2024 chempedia.info